Oleaside B is primarily studied for its potential neuroprotective and anti-inflammatory properties. It has shown promise in research related to neurodegenerative conditions such as Alzheimer’s disease, where it may help reduce oxidative stress and inhibit the aggregation of amyloid-beta peptides, a key factor in disease progression. Its ability to cross the blood-brain barrier enhances its suitability for central nervous system-targeted therapies. Additionally, Oleaside B exhibits antioxidant activity, making it a candidate for use in formulations aimed at cellular protection against free radical damage. While still in the preclinical research phase, it holds interest for development in pharmaceuticals focused on brain health and aging-related cognitive decline.